PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib.
Gynecol Oncol
; 155(1): 144-150, 2019 10.
Article
in En
| MEDLINE
| ID: mdl-31434613
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phthalazines
/
Piperazines
/
Uterine Cervical Neoplasms
/
Poly(ADP-ribose) Polymerase Inhibitors
/
Poly (ADP-Ribose) Polymerase-1
Type of study:
Diagnostic_studies
Limits:
Adult
/
Animals
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Gynecol Oncol
Year:
2019
Type:
Article
Affiliation country:
United States